Peptide Library Add to a stack
MetabolicTH9507Egrifta
Tesamorelin
A stabilized GHRH analog studied for visceral adipose tissue reduction.
Half-life
~25–40 minutes
Schedule
daily
Cycle
12–26 wks
Mechanism of action
Potent GHRH receptor agonist increasing GH/IGF-1, with notable effects on visceral fat in clinical research.
Potential applications
Visceral fat researchMetabolic
Dosing information
Clinical research has used ~1–2 mg daily subcutaneously.
For research and educational reference only — not a dosing recommendation.
Research references
Aether Pulse provides educational and research information only. Content is not medical advice. Products are sold for research use only. Consult a qualified professional before making health decisions.